Sapiens Reports Q2 2025 Revenue Increase of 3.5%, Net Income Decline of 23.6%, and EPS Drop of 24.2%

Reuters
08/13
Sapiens Reports <a href="https://laohu8.com/S/QTWO">Q2</a> 2025 Revenue Increase of 3.5%, Net Income Decline of 23.6%, and EPS Drop of 24.2%

Sapiens International Corporation NV, a global provider of software solutions for the insurance industry, reported its financial results for the second quarter ended June 30, 2025. The company saw a 3.5% increase in revenue, reaching $141.6 million compared to $136.8 million in the same period in 2024. Gross profit also rose by 3.0% to $61.9 million from $60.1 million in the previous year, while the gross margin slightly decreased to 43.7% from 43.9%. However, Sapiens experienced a decline in operating income, which fell by 23.2% to $16.8 million from $21.9 million in the second quarter of 2024. The operating margin decreased to 11.9% from 16.0%. Net income attributable to Sapiens' shareholders dropped by 23.6% to $14.2 million from $18.6 million in the prior year. Earnings per share $(EPS)$ also saw a decrease, with diluted EPS at $0.25, down 24.2% from $0.33 in the same quarter last year. During the quarter, Sapiens completed the acquisitions of Advantage Go and Candella, strengthening its growth in the Property & Casualty (P&C) and Life segments. The company continues to focus on platform innovation, cross-selling, cloud adoption, and expanding its Life & Annuities business globally, aiming for accelerated growth in 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sapiens International Corporation NV published the original content used to generate this news brief via PR Newswire (Ref. ID: IO46562) on August 13, 2025, and is solely responsible for the information contained therein.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10